Načítá se...
Contemporary therapeutics and new drug developments for treatment of Fabry disease: a narrative review
Fabry disease (OMIM 301500) is an X-linked (Xq22.1) lysosomal storage disorder leading to a progressive multisystem disease with high variability in both genotype and phenotype expression. The pathophysiological origin is found in an enzyme deficiency of the α-galactosidase A (enzyme commission no....
Uloženo v:
| Vydáno v: | Cardiovasc Diagn Ther |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8102271/ https://ncbi.nlm.nih.gov/pubmed/33968645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/cdt-20-743 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|